ClinicalTrials.Veeva

Menu

Korean Idiopathic Pulmonary Fibrosis Registry

Seoul National University logo

Seoul National University

Status

Enrolling

Conditions

Idiopathic Pulmonary Fibrosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.

Full description

Korean ILD Study Group includes investigators of 30 hospitals. Demographic, pulmonary function, laboratory data, chest CT findings and hospital course of IPF patients are collected.

Enrollment

3,000 estimated patients

Sex

All

Ages

30 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IPF patients diagnosed by multidisciplinary discussion

Exclusion criteria

  • Other interstitial lung diseases except for IPF
  • connective tissue disease-related ILD
  • exposure-related ILD

Trial contacts and locations

1

Loading...

Central trial contact

Jong Sun Park, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems